Although down-regulation of NR3C2 was reported in COAD and its high expression predicted good prognosis (24), we found the distinct expression trend of NR3C2 in the epithelium and mesenchyme, indicating further experiments are needed to explore their exact function. The gene discussed is NR3C2; the disease is colon adenocarcinoma.